Dr. Casimiro Gonzalez, MD

Dr. Gonzalez practices at Buena Vista Eye Clinic in Bell, California.

Dr. Gonzalez's NPI, 1851497911, was assigned on September 16, 2006. Dr. Gonzalez graduated from UC San Diego School of Medicine in 1994. Dr. Gonzalez holds California license A66511.

Dr. Gonzalez's primary practice is Buena Vista Eye Clinic, at 6930 S Atlantic Ave, Bell, CA 90201 in Los Angeles County. The practice phone is (323) 562-0055.

Dr. Gonzalez's primary practice is Buena Vista Eye Clinic in Bell, California. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Gonzalez to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonzalez practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gonzalez's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gonzalez is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Gonzalez is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Gonzalez treats.

CMS data shows 1,768 Medicare services from Dr. Gonzalez across 17 procedure codes in 2024, for 628 Medicare patients. Medicare paid $176,086 for them.

CMS counts 628 Medicare patients who saw Dr. Gonzalez in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 93% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gonzalez's median patient age at 66, with 58% women.

In 2024, Dr. Gonzalez wrote 10,556 Medicare Part D claims for 2,115 patients. CMS names the drug for 10,419 of them, across 35 drugs with 11 or more claims each, at $1,765,776 in total drug cost. In 2023, CMS named 10,734 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gonzalez for performance year 2024, reported as part of a group. Dr. Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 162 procedures of cataract surgery by Dr. Gonzalez, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Gonzalez. The most frequent topics are Cytomegalovirus Retinitis. Dr. Gonzalez's most frequent co-authors are William R. Freeman, MD, Roberto F. Garcia, MD and Leonard Scott Kirsch, MD.

CMS Open Payments shows 483 general payments to Dr. Gonzalez from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Alcon Laboratories Inc paid the most, $2,014.

Dmand AI lists 2 awards for Dr. Gonzalez, most recently CMS Stage 1 2012 in 2011.

Dr. Gonzalez graduated from UC San Diego School of Medicine in 1994. Dr. Gonzalez is a member of AAO.

Dr. Gonzalez is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.